Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 simultaneously alleviate ethanol-induced gastritis and hepatic injury in mice

Journal of Functional Foods

Volumn 38, Issue , 2017, Pages 389-398

  Kwon, Eun Kyung ^a   Kang, Geum Dan ^a   Kim, Won Kyeong ^a   Han, Myung Joo ^a   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Bifidobacterium longum; Ethanol; Gastritis; Lactobobacillus plantarum; Liver injury; Probiotic

Indexed keywords

EID: 85029687603     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2017.09.036     Document Type: Article

References (54)

1. Atkinson, K.J., Rao, R.K., Role of protein tyrosine phosphorylation in acetaldehyde-induced disruption of epithelial tight junctions. American Journal of Physiology. Gastrointestinal and Liver Physiology 280 (2001), G1280–G1288.
2. Bajaj, J.S., Hylemon, P.B., Ridlon, J.M., Heuman, D.M., Daita, K., White, M.B., Gillevet, P.M., Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Alcoholism: Clinical and Experimental Research 303 (2012), G675–685.
3. Barone, R., Rappa, F., Macaluso, F., Caruso Bavisotto, C., Sangiorgi, C., Di Paola, G., Marino Gammazza, A., Alcoholic Liver Disease: A Mouse Model Reveals Protection by Lactobacillus fermentum. Clinical and Translational Gastroenterology, 7, 2016, e138.
4. Bautista, A.P., Neutrophilic infiltration in alcoholic hepatitis. Alcohol 27 (2002), 17–21.
5. Bawa, M., Saraswat, V.A., Gut-liver axis: Role of inflammasomes. Journal of Clinical and Experimental Hepatology 3 (2013), 141–149.
6. Behnsen, J., Deriu, E., Sassone-Corsi, M., Raffatellu, M., Probiotics: Properties, examples, and specific applications. Cold Spring Harbor Perspective in Medicine, 3, 2013, a010074.
7. Bellavia, M., Rappa, F., Lo Bello, M., Brecchia, G., Tomasello, G., Leone, A., Traina, G., Lactobacillus casei and bifidobacterium lactis supplementation reduces tissue damage of intestinal mucosa and liver after 2,4,6-trinitrobenzenesulfonic acid treatment in mice. Journal of Biological Regulators and Homeostatic Agents 28 (2014), 251–261.
8. Bode, C., Bode, J.C., Alcohol's role in gastrointestinal tract disorders. Alcohol Health and Research World 21 (1997), 76–83.
9. Bujanda, L., The effects of alcohol consumption upon the gastrointestinal tract. American Journal of Gastroenterology 95 (2000), 3374–3382.
10. Chiu, Y.H., Tsai, J.J., Lin, S.L., Lin, M.Y., Lactobacillus casei MYL01 modulates the proinflammatory state induced by ethanol in an in vitro model. Journal of Dairy Science 97 (2014), 2009–2016.
11. Dehmlow, C., Erhard, J., de Groot, H., Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin. Hepatology 23 (1996), 749–754.
12. Dhanda, A.D., Lee, R.W., Collins, P.L., McCune, C.A., Molecular targets in the treatment of alcoholic hepatitis. World Journal of Gastroenterology 18 (2012), 5504–5513.
13. Ghosh, S., Hayden, M.S., New regulators of NF-kappaB in inflammation. Nature Reviews Immunology 8 (2008), 837–848.
14. 4-induced fibrosis. PLoS ONE, 6, 2011, e23037.
15. Gonzalez-Quintela, A., Dominguez-Santalla, M.J., Perez, L.F., Vidal, C., Lojo, S., Barrio, E., Influence of acute alcohol intake and alcohol withdrawal on circulating levels of IL-6, IL-8, IL-10 and IL-12. Cytokine 12 (2000), 1437–1440.
16. Guslandi, M., Effects of ethanol on the gastric mucosa. Digestive Diseases 5 (1987), 21–32.
17. Han, S.Y., Huh, C.S., Ahn, Y.T., Lim, K.S., Baek, Y.J., Kim, D.H., Hepatoprotective effect of lactic acid bacteria, inhibitors of beta-glucuronidase production against intestinal microflora. Archives of Pharmacal Research 28 (2005), 325–329.
18. Hijioka, T., Sato, N., Matsumura, T., Yoshihara, H., Takei, Y., Fukui, H., Kamada, T., Ethanol-induced disturbance of hepatic microcirculation and hepatic hypoxia. Biochemical Pharmacology 41 (1991), 1551–1557.
19. Hoek, J.B., Pastorino, J.G., Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 27 (2002), 63–68.
20. Jafarpour, D., Shekarforoush, S.S., Ghaisari, H.R., Nazifi, S., Sajedianfard, J., Eskandari, M.H., Protective effects of synbiotic diets of Bacillus coagulans, Lactobacillus plantarum and inulin against acute cadmium toxicity in rats. BMC Complementary and Alternative Medicine, 17, 2017, 291.
21. Jeong, J.J., Jang, S.E., Hyam, S.R., Han, M.J., Kim, D.H., Mangiferin ameliorates colitis by inhibiting IRAK1 phosphorylation in NF-κB and MAPK pathways. European Journal of Pharmacology 740 (2014), 652–661.
22. Kang, H.J., Im, S.H., Probiotics as an Immune Modulator. Journal of Nutritional Science and Vitaminology 61:Suppl (2015), S103–105.
23. Kang, G.D., Kim, D.H., Ponciretin attenuates ethanol-induced gastric damage in mice by inhibiting inflammatory responses. International Immunopharmacology 43 (2016), 179–186.
24. Kang, G.D., Lee, S.Y., Jang, S.E., Han, M.J., Kim, D.H., Irisolidone attenuates ethanol-induced gastric injury in mice by inhibiting the infiltration of neutrophils. Molecular Nutrition and Food Research, 2017, 10.1002/mnfr.201600517.
25. Kim, K.A., Jeong, J.J., Kim, D.H., Lactobacillus brevis OK56 ameliorates high-fat diet-induced obesity in mice by inhibiting NF-κB activation and gut microbial LPS production. Journal of Functional Foods 13 (2015), 183–191.
26. Klingman, G.I., Haag, H.B., Studies on severe alcohol intoxication in dogs. I. Blood and urinary changes in lethal intoxication. Journal of Studies on Alcohol and Drugs 19 (1958), 203–225.
27. Konturek, P.C., Brzozowski, T., Konturek, S.J., Stachura, J., Karczewska, E., Pajdo, R., Hahn, E.G., Mouse model of Helicobacter pylori infection: Studies of gastric function and ulcer healing. Alimentary Pharmacology & Therapeutics 13 (1999), 333–346.
28. Kumar, H., Salminen, S., Verhagen, H., Rowland, I., Heimbach, J., Bañares, S., Lalonde, M., Novel probiotics and prebiotics: Road to the market. Current Opinion in Biotechnology 32 (2015), 99–103.
29. Kawaratani, H., Tsujimoto, T., Douhara, A., Takaya, H., Moriya, K., Namisaki, T., Fukui, H., The effect of inflammatory cytokines in alcoholic liver disease. Mediators of Inflammation, 2013, 2013, 495156.
30. Lim, S.M., Jeong, J.J., Jang, S.E., Han, M.J., Kim, D.H., A mixture of the probiotic strains Bifidobacterium longum CH57 and Lactobacillus brevis CH23 ameliorates colitis in mice by inhibiting macrophage activation and restoring the Th17/Treg balance. Journal of Functional Foods 27 (2016), 295–309.
31. Loguercio, C., Federico, A., Tuccillo, C., Terracciano, F., D'Auria, M.V., De Simone, C., Del Vecchio Blanco, C., Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. Journal of Clinical Gastroenterology 39 (2005), 540–543.
32. Malaguarnera, G., Giordano, M., Nunnari, G., Bertino, G., Malaguarnera, M., Gut microbiota in alcoholic liver disease: Pathogenetic role and therapeutic perspectives. World Journal of Gastroenterology 20 (2014), 16639–16648.
33. Mutlu, E.A., Gillevet, P.M., Rangwala, H., Sikaroodi, M., Naqvi, A., Engen, P.A., Keshavarzian, A., Colonic microbiome is altered in alcoholism. American Journal of Physiology. Gastrointestinal and Liver Physiology 302 (2012), G966–978.
34. Nair, S., Cope, K., Risby, T.H., Diehl, A.M., Obesity and female gender increase breath ethanol concentration: Potential implications for the pathogenesis of nonalcoholic steatohepatitis. The American Journal of Gastroenterology 96 (2001), 1200–1204.
35. Orman, E.S., Odena, G., Bataller, R., Alcoholic liver disease: Pathogenesis, management, and novel targets for therapy. Journal of Gastroenterology and Hepatology 28:Suppl 1 (2013), 77–84.
36. Park, B., Lee, H.R., Lee, Y.J., Alcoholic liver disease: focus on prodromal gut health. Journal of Digestive Diseases 17 (2016), 493–500.
37. Park, S.W., Oh, T.Y., Kim, Y.S., Sim, H., Park, S.J., Jang, E.J., Hahm, K.B., Artemisia asiatica extracts protect against ethanol-induced injury in gastric mucosa of rats. Journal of Gastroenterology and Hepatology 23 (2008), 976–984.
38. Petrof, E.O., Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science. Antiinflammatory & Antiallergy Agents in Medicinal Chemistry 8 (2009), 260–269.
39. Rao, R.K., Seth, A., Sheth, P., Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. American Journal of Physiology. Gastrointestinal and Liver Physiology 286 (2004), G881–884.
40. Segawa, S., Wakita, Y., Hirata, H., Watari, J., Oral administration of heat-killed Lactobacillus brevis SBC8803 ameliorates alcoholic liver disease in ethanol-containing diet-fed C57BL/6N mice. Internatinal Journal of Food Microbiology 128 (2008), 371–377.
41. Stadlbauer, V., Mookerjee, R.P., Hodges, S., Wright, G.A., Davies, N.A., Jalan, R., Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. Journal of Hepatology 48 (2008), 945–951.
42. Sung, H., Kim, S.W., Hong, M., Suk, K.H., Microbiota-based treatments in alcoholic liver disease. World Journal of Gastroenterology 22 (2016), 6673–6682.
43. Suo, H., Zhao, X., Qian, Y., Sun, P., Zhu, K., Li, J., Sun, B., Lactobacillus fermentum Suo attenuates HCl/ethanol induced gastric injury in mice through its antioxidant effects. Nutrients, 8, 2016, 155.
44. Szabady, R.L., McCormick, B.A., Control of neutrophil inflammation at mucosal surfaces by secreted epithelial products. Frontiers in Immunology, 4, 2013, 220.
45. Szabo, G., Bala, S., Petrasek, J., Gattu, A., Gut-liver axis and sensing microbes. Digestive Diseases 28 (2010), 737–744.
46. Tang, Y., Forsyth, C.B., Farhadi, A., Rangan, J., Jakate, S., Shaikh, M., Keshavarzian, A., Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage. Alcoholism: Clinical and Experimental Research 33 (2009), 1220–1230.
47. Tian, F., Chi, F., Wang, G., Liu, X., Zhang, Q., Chen, Y., Chen, W., Lactobacillus rhamnosus CCFM1107 treatment ameliorates alcohol-induced liver injury in a mouse model of chronic alcohol feeding. Journal of Microbiology 53 (2015), 856–863.
48. Tian, F., Yu, L., Zhai, Q., Xiao, Y., Shi, Y., Jiang, J., Chen, W., The therapeutic protection of a living and dead Lactobacillus strain against aluminum-induced brain and liver injuries in C57BL/6 mice. PLoS ONE, 12, 2017, e0175398.
49. Traina, G., Menchetti, L., Rappa, F., Casagrande-Proietti, P., Barbato, O., Leonardi, L., Brecchia, G., Probiotic mixture supplementation in the preventive management of trinitrobenzenesulfonic acid-induced inflammation in a murine model. Journal of Biological Regulators and Homeostatic Agents 30 (2016), 895–901.
50. Vijaya Kumar, B., Vijayendra, S.V., Reddy, O.V., Trends in dairy and non-dairy probiotic products – A review. Journal of Food Science and Technology 52 (2015), 6112–6124.
51. Wigg, A.J., Roberts-Thomson, I.C., Dymock, R.B., McCarthy, P.J., Grose, R.H., Cummins, A.G., The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48 (2001), 206–211.
52. Woods, S.E., Hitchcock, M., Meyer, A., Alcoholic hepatitis. American Family Physician 47 (1993), 1171–1178.
53. Yang, S.Q., Lin, H.Z., Lane, M.D., Clemens, M., Diehl, A.M., Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis. Proceedings of the National Academy of Sciences of the United States of America 94 (1997), 2557–2562.
54. Zhao, H., Zhao, C., Dong, Y., Zhang, M., Wang, Y., Li, F., Li, X., McClain, C., Yang, S., Feng, W., Inhibition of miR122a by Lactobacillus rhamnosus GG culture supernatant increases intestinal occludin expression and protects mice from alcoholic liver disease. Toxicology Letters 234 (2015), 194–200.